Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Symmans

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survivalF Bertucci, N T Ueno, P Finetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2022
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trialC E Geyer, W M Sikov, J Huober, et al.
Nature Communications|December 1, 2018
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancerGloria V Echeverria, Emily Powell, Sahil Seth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
NPJ Breast Cancer|May 9, 2018
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasisEmily Powell, Jiansu Shao, Hector M Picon, et al.
Iscience|January 8, 2026
EMT-induced stem cell and mesenchymal programs can be decoupled via cell division and ESRP1-dependent mechanismsPetra den Hollander, Maria Castaneda, Suhas V Vasaikar, et al.
Communications Medicine|January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Human Pathology|April 25, 2018
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancerQingqing Ding, Yan Wang, Zhuang Zuo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2025
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trialN Harbeck, S Modi, L Pusztai, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survivalF Bertucci, N T Ueno, P Finetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2022
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trialC E Geyer, W M Sikov, J Huober, et al.
Nature Communications|December 1, 2018
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancerGloria V Echeverria, Emily Powell, Sahil Seth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
NPJ Breast Cancer|May 9, 2018
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasisEmily Powell, Jiansu Shao, Hector M Picon, et al.
Iscience|January 8, 2026
EMT-induced stem cell and mesenchymal programs can be decoupled via cell division and ESRP1-dependent mechanismsPetra den Hollander, Maria Castaneda, Suhas V Vasaikar, et al.
Communications Medicine|January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Human Pathology|April 25, 2018
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancerQingqing Ding, Yan Wang, Zhuang Zuo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2025
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trialN Harbeck, S Modi, L Pusztai, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Pageof 10